United States Supreme Court. BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC., ET AL., (2011). No. 09-152. Argued: October 12, 2010 Decided: February 22, 2011. The National Childhood Vaccine Injury Act of 1986 (NCVIA or Act) created a no-fault compensation program to stabilize a vaccine market adversely ...
Jul 26, 1990 ... Salasguevara v. Wyeth Laboratories, Inc. (1990) - 222 Cal. App. 3d 379, 271 Cal. Rptr. 780. ... WYETH LABORATORIES, INC. et al., Defendants and Respondents. [Opinion certified for ... Sheela & Sheela, Barton Sheela, Richard Amerian and Sharon Munson Swanson for Plaintiff and Appellant. Morgan ...
Oct 12, 2010 ... After their daughter suffered severe health problems following a routine vaccination for diphtheria-tetanus-pertussis (“DTP”), Russell and Robalee Bruesewitz sued Wyeth, Inc., the manufacturer of the vaccine, alleging that Wyeth's DTP vaccine was outmoded and inadequately designed. In response, Wyeth ...
Aug 29, 2017 ... glutamatergic principal cells, but their roles in GABAergic interneurons remain unexplored. Wyeth et al. find that somatodendritic KARs within diverse interneurons require ... Fisher and Mott, 2012, 2013; Griffith and Swanson, 2015; Orav et al., 2017 ..... (2 mice and 4 cells each, *p < 0.05 each versus WT).
Frederick Radintz, et al., Respondents, Carla Manuel, et al., Respondents. A09- 284, James J. Benincasa, et al., Appellants, vs. Michael J. Antonello, et al., Defendants, Benistar 419 Plan Services, Inc., plan sponsor for the Benistar 419 Plan and Trust, et al., Respondents, The Lafayette Life Insurance Company, Respondent.
Sep 15, 2017 ... Recently, Neto1 was found to regulate tonic suppression of transmission at neonatal CA3 to CA1 pyramidal synapses by presynaptic GluK1 (Orav et al., 2017) while Neto2 was confirmed as an auxiliary subunit of native GluK1- containing KARs in peripheral sensory neurons (Vernon and Swanson, 2017) ...
Aug 13, 2015 ... The response of GluK1 receptors showed little recovery at this time point, consistent with previous reports (Swanson & Heinemann, 1998; Copits et al., .... However, the stoichiometric relationships for these different functional interactions (i.e. the number of Neto subunits required for full kinetic effects vs.
Glutamate-evoked currents in DRG neurons have properties similar to GluK1- containing receptors (Swanson and Heinemann, 1998), although there is evidence for GluK5 mRNA (Herb et al., 1992; Partin et al., 1993) and Neto mRNA in DRG (Allen Institute for Brain Science, 2015). The role of KARs in peripheral neurons is ...
Jan 29, 2008 ... f Bioanalytical R&D, Drug Safety and Metabolism, Wyeth Research, Andover MA 01810, USA g Clinical discovery, Bristol-Myers Squibb ..... neutralizing IgG4 and IgG1 antibodies (Swanson et al.,. 2004). In contrast, low-affinity, ... risk versus benefit assessment of therapeutic proteins. 4. Antibody testing.